| Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma MP Chao, AA Alizadeh, C Tang, JH Myklebust, B Varghese, S Gill, M Jan, ... Cell 142 (5), 699-713, 2010 | 1164 | 2010 |
| Tuning the antigen density requirement for CAR T-cell activity RG Majzner, SP Rietberg, E Sotillo, R Dong, VT Vachharajani, ... Cancer discovery 10 (5), 702-723, 2020 | 368 | 2020 |
| Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma MR Green, AJ Gentles, RV Nair, JM Irish, S Kihira, CL Liu, I Kela, ... Blood, The Journal of the American Society of Hematology 121 (9), 1604-1611, 2013 | 364 | 2013 |
| The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin … SE Jacobsen, C Okkenhaug, J Myklebust, OP Veiby, SD Lyman The Journal of experimental medicine 181 (4), 1357-1363, 1995 | 226 | 1995 |
| Characterization of early stages of human B cell development by gene expression profiling ME Hystad, JH Myklebust, TH Bø, EA Sivertsen, E Rian, L Forfang, ... The Journal of Immunology 179 (6), 3662-3671, 2007 | 219 | 2007 |
| Prediction of survival in diffuse large B-cell lymphoma based on the expression of 2 genes reflecting tumor and microenvironment AA Alizadeh, AJ Gentles, AJ Alencar, CL Liu, HE Kohrt, R Houot, ... Blood, The Journal of the American Society of Hematology 118 (5), 1350-1358, 2011 | 207 | 2011 |
| Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21‐ras (12VAL) peptide vaccination of a patient, recognize 12VAL‐dependent nested epitopes … MK Gjertsen, J Bjørheim, I Saeterdal, J Myklebust, G Gaudernack International journal of cancer 72 (5), 784-790, 1997 | 194 | 1997 |
| B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression JM Irish, JH Myklebust, AA Alizadeh, R Houot, JP Sharman, ... Proceedings of the National Academy of Sciences 107 (29), 12747-12754, 2010 | 190 | 2010 |
| High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells JH Myklebust, JM Irish, J Brody, DK Czerwinski, R Houot, HE Kohrt, ... Blood, The Journal of the American Society of Hematology 121 (8), 1367-1376, 2013 | 187 | 2013 |
| Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer T Cabezón, JE Celis, I Skibshøj, J Klingelhöfer, M Grigorian, P Gromov, ... International journal of cancer 121 (7), 1433-1444, 2007 | 167 | 2007 |
| Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by Treg depletion R Houot, MJ Goldstein, HE Kohrt, JH Myklebust, AA Alizadeh, JT Lin, ... Blood, The Journal of the American Society of Hematology 114 (16), 3431-3438, 2009 | 165 | 2009 |
| Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34+ hematopoietic progenitor cells JH Myklebust, HK Blomhoff, LS Rusten, T Stokke, EB Smeland Experimental hematology 30 (9), 990-1000, 2002 | 143 | 2002 |
| The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma CB Steen, BA Luca, MS Esfahani, A Azizi, BJ Sworder, BY Nabet, ... Cancer cell 39 (10), 1422-1437. e10, 2021 | 135 | 2021 |
| TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma SE Josefsson, K Beiske, YN Blaker, MS Førsund, H Holte, B Østenstad, ... Cancer immunology research 7 (3), 355-362, 2019 | 102 | 2019 |
| BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1 C Kersten, EA Sivertsen, ME Hystad, L Forfang, EB Smeland, ... BMC immunology 6, 1-13, 2005 | 95 | 2005 |
| T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling SE Josefsson, K Huse, A Kolstad, K Beiske, D Pende, CB Steen, ... Clinical Cancer Research 24 (4), 870-881, 2018 | 92 | 2018 |
| Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling JH Myklebust, J Brody, HE Kohrt, A Kolstad, DK Czerwinski, S Wälchli, ... Blood, The Journal of the American Society of Hematology 129 (6), 759-770, 2017 | 90 | 2017 |
| Protein kinase C-α isoform is involved in erythropoietin-induced erythroid differentiation of CD34+ progenitor cells from human bone marrow JH Myklebust, EB Smeland, D Josefsen, M Sioud Blood, The Journal of the American Society of Hematology 95 (2), 510-518, 2000 | 86 | 2000 |
| Activation of the cAMP signaling pathway increases apoptosis in human B‐precursor cells and is associated with downregulation of Mcl‐1 expression JH Myklebust, D Josefsen, HK Blomhoff, FO Levy, S Naderi, JC Reed, ... Journal of cellular physiology 180 (1), 71-80, 1999 | 85 | 1999 |
| Artesunate shows potent anti-tumor activity in B-cell lymphoma TK Våtsveen, MR Myhre, CB Steen, S Wälchli, OC Lingjærde, B Bai, ... Journal of hematology & oncology 11, 1-12, 2018 | 79 | 2018 |
Ash A. Alizadeh, MD, PhDStanford University, Moghadam Family Professor of Medicine在 stanford.edu 的电子邮件经过验证
